Cite
Chimeric antigen receptor-engineered T cells for cancer immunotherapy: progress and challenges.
MLA
Han, Ethan Q., et al. “Chimeric Antigen Receptor-Engineered T Cells for Cancer Immunotherapy: Progress and Challenges.” Journal of Hematology & Oncology, vol. 6, July 2013, p. 47. EBSCOhost, https://doi.org/10.1186/1756-8722-6-47.
APA
Han, E. Q., Li, X., Wang, C., Li, T., & Han, S. (2013). Chimeric antigen receptor-engineered T cells for cancer immunotherapy: progress and challenges. Journal of Hematology & Oncology, 6, 47. https://doi.org/10.1186/1756-8722-6-47
Chicago
Han, Ethan Q, Xiu-ling Li, Chun-rong Wang, Tian-fang Li, and Shuang-yin Han. 2013. “Chimeric Antigen Receptor-Engineered T Cells for Cancer Immunotherapy: Progress and Challenges.” Journal of Hematology & Oncology 6 (July): 47. doi:10.1186/1756-8722-6-47.